ATG4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.58046966811798E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.28000000002115E-06 |
Normal-vs-Stage2 |
3.764400E-03 |
Normal-vs-Stage3 |
1.80366832580603E-12 |
Normal-vs-Stage4 |
2.0925483568135E-12 |
Stage1-vs-Stage2 |
6.843600E-01 |
Stage1-vs-Stage3 |
8.234400E-04 |
Stage1-vs-Stage4 |
3.66579999999672E-05 |
Stage2-vs-Stage3 |
9.155600E-02 |
Stage2-vs-Stage4 |
1.128080E-02 |
Stage3-vs-Stage4 |
2.050600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.84849929702114E-11 |
Normal-vs-AfricanAmerican |
1.841460E-04 |
Normal-vs-Asian |
3.60169999999993E-05 |
Caucasian-vs-AfricanAmerican |
5.562600E-01 |
Caucasian-vs-Asian |
2.097800E-01 |
AfricanAmerican-vs-Asian |
4.474400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.79359868571305E-11 |
Normal-vs-Female |
7.25469995188632E-09 |
Male-vs-Female |
6.101800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.524150E-03 |
Normal-vs-Age(41-60Yrs) |
3.15689996366331E-09 |
Normal-vs-Age(61-80Yrs) |
1.50609968940785E-10 |
Normal-vs-Age(81-100Yrs) |
1.390420E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.490000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.281800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.552800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.758200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.613000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.187600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.817200E-01 |
Normal-vs-Grade 2 |
1.11359999999117E-06 |
Normal-vs-Grade 3 |
7.10553837990346E-12 |
Normal-vs-Grade 4 |
4.23659995973935E-11 |
Grade 1-vs-Grade 2 |
2.870000E-01 |
Grade 1-vs-Grade 3 |
5.753500E-02 |
Grade 1-vs-Grade 4 |
8.362300E-03 |
Grade 2-vs-Grade 3 |
5.456700E-03 |
Grade 2-vs-Grade 4 |
1.181250E-04 |
Grade 3-vs-Grade 4 |
9.565800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.33140000030596E-07 |
Normal-vs-ccB subtype |
6.14980000257503E-08 |
ccA subtype-vs-ccB subtype |
1.237440E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.30889990354899E-10 |
Normal-vs-N1 |
2.807000E-04 |
N0-vs-N1 |
2.779900E-02 |
|
|